It will be important to understand whether MNK inhibition will interfere with the anti-cancer activity of the chemotherapeutic, but this is unlikely since increased MNK activity and increased eIF4E phosphorylation is associated with many cancers (69, 70) and MNK inhibitors are currently in clinical trials for cancer treatment (71). This evidence concerns the gene EIF4E and cancer.